Vinpocetine

Vinpocetine is a derivative from the Periwinkle plant that safely and effectively restores failing neuronal energy. Vinpocetine functions as a cerebral metabolic enhancer and cerebral vasodilator. It enhances oxygen and glucose uptake from blood by brain neurons and increases neuronal ATP bio-energy production, even under hypoxic (low oxygen) conditions. Vinpocetine enhances both glycolytic and oxidative reactions of glucose breakdown for a higher level of brain energy production.

• Vinpocetine dilates the arteries of the brain but does not dilate other blood vessels.
• Vinpocetine improves the brain's utilization of glucose.
• Vinpocetine accelerates the rate of learning in animal studies by up to 40%.
• Vinpocetine increases the length of time that short-term memory is retained.
• Vinpocetine may improve vision and eyesight disorders.
• Vinpocetine improves impaired hearing and improves inner-ear problems.
• Vinpocetine increases Adenosine Triphosphate (ATP) within the brain's neurons.

SPECIAL ONLINE PRICE
$19.95 per bottle (60 capsules - 20mg)

These statements have not been evaluated by the Food and Drug Administration.

1. Subhan Z; Hindmarch I. Psychopharmacological effects of vinpocetine in normal healthy volunteers. Eur J Clin Pharmacol. 28:567-571, 1985.
   
   
2. Coleston DM. Hindmarch I. Possible memory-enhancing properties of vinpocetine. Drug Dev Res. 14:191-193, 1988
   
   
3. Kiss B; Szporny L. On the possible role of central monoaminergic systems in the central nervous system actions of vinpocetine. Drug Dev Res. 14:263-279, 1988
   
   
4. Miskolczi P; et al. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans. Eur J Drug Metab Pharmacokinet. 15:1-5, 1990
   
   
5. Miyamoto M; et al. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther. 250:1132-1140, 1989
   
   
6. Olah VA; et al. An in vitro study of the hydroxyl scavenger effect of Cavinton. Acta Paediatr Hung. 30:309-316, 1990
   
   
7. Uchiyama-Tsuyuki Y; et al. VA-045, a novel apovincamic acid derivative attenuates neuronal injury induced by hypoxia or by excitatory amino acids in cultures of rat cortices. Life Sci. 59:1571-1578, 1996
   
   
8. Rischke R; Krieglstein J. Effects of vinpocetine on local cerebral blood flow and glucose utilization seven days after forebrain ischemia in the rat. Pharmacology. 41:153-160, 1990
   
   
9. Manconi E; et al. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. Curr Ther Res Clin Exp. 40:702-709, 1986
   
   
10. Dezsi L , et al. Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke. Acta Pharm Hung 2002;72(2):84-91